300 related articles for article (PubMed ID: 29604203)
1. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer.
Di Meo A; Wang C; Cheng Y; Diamandis EP; Yousef GM
Biol Chem; 2018 Sep; 399(9):973-982. PubMed ID: 29604203
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.
Pasic MD; Olkhov E; Bapat B; Yousef GM
Biol Chem; 2012 Apr; 393(5):319-30. PubMed ID: 22505515
[TBL] [Abstract][Full Text] [Related]
3. The miRNA-kallikrein axis of interaction: a new dimension in the pathogenesis of prostate cancer.
White NM; Youssef YM; Fendler A; Stephan C; Jung K; Yousef GM
Biol Chem; 2012 Apr; 393(5):379-89. PubMed ID: 22505520
[TBL] [Abstract][Full Text] [Related]
4. microRNAs: a new frontier in kallikrein research.
Yousef GM
Biol Chem; 2008 Jun; 389(6):689-94. PubMed ID: 18627305
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
White NM; Bui A; Mejia-Guerrero S; Chao J; Soosaipillai A; Youssef Y; Mankaruos M; Honey RJ; Stewart R; Pace KT; Sugar L; Diamandis EP; Doré J; Yousef GM
Biol Chem; 2010 Apr; 391(4):411-23. PubMed ID: 20180642
[TBL] [Abstract][Full Text] [Related]
6. Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.
White NM; Chow TF; Mejia-Guerrero S; Diamandis M; Rofael Y; Faragalla H; Mankaruous M; Gabril M; Girgis A; Yousef GM
Br J Cancer; 2010 Apr; 102(8):1244-53. PubMed ID: 20354523
[TBL] [Abstract][Full Text] [Related]
7. Kallikreins are involved in an miRNA network that contributes to prostate cancer progression.
Samaan S; Lichner Z; Ding Q; Saleh C; Samuel J; Streutker C; Yousef GM
Biol Chem; 2014 Sep; 395(9):991-1001. PubMed ID: 25153383
[TBL] [Abstract][Full Text] [Related]
8. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.
Avgeris M; Scorilas A
Expert Opin Ther Targets; 2016 Jul; 20(7):801-18. PubMed ID: 26941073
[TBL] [Abstract][Full Text] [Related]
10. Overview of tissue kallikrein and kallikrein-related peptidases in breast cancer.
Figueroa CD; Molina L; Bhoola KD; Ehrenfeld P
Biol Chem; 2018 Sep; 399(9):937-957. PubMed ID: 29885274
[TBL] [Abstract][Full Text] [Related]
11. Kallikrein-related peptidases and associated microRNAs as promising prognostic biomarkers in gastrointestinal malignancies.
Adamopoulos PG; Tsiakanikas P; Scorilas A
Biol Chem; 2018 Jul; 399(8):821-836. PubMed ID: 29883317
[TBL] [Abstract][Full Text] [Related]
12. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers.
Kontos CK; Scorilas A
Clin Chem Lab Med; 2012 Nov; 50(11):1877-91. PubMed ID: 23093268
[TBL] [Abstract][Full Text] [Related]
13. Predictions for the future of kallikrein-related peptidases in molecular diagnostics.
Scorilas A; Mavridis K
Expert Rev Mol Diagn; 2014 Jul; 14(6):713-22. PubMed ID: 24927162
[TBL] [Abstract][Full Text] [Related]
14. The epigenetic basis for the aberrant expression of kallikreins in human cancers.
Pampalakis G; Diamandis EP; Sotiropoulou G
Biol Chem; 2006 Jun; 387(6):795-9. PubMed ID: 16800742
[TBL] [Abstract][Full Text] [Related]
15. Functional roles of human kallikrein-related peptidases.
Sotiropoulou G; Pampalakis G; Diamandis EP
J Biol Chem; 2009 Nov; 284(48):32989-94. PubMed ID: 19819870
[TBL] [Abstract][Full Text] [Related]
16. Kallikrein-related peptidases (KLKs) and the hallmarks of cancer.
Filippou PS; Karagiannis GS; Musrap N; Diamandis EP
Crit Rev Clin Lab Sci; 2016 Aug; 53(4):277-91. PubMed ID: 26886390
[TBL] [Abstract][Full Text] [Related]
17. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
Emami N; Diamandis EP
Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.
Avgeris M; Mavridis K; Scorilas A
Biol Chem; 2010 May; 391(5):505-11. PubMed ID: 20302518
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.
Dorn J; Bayani J; Yousef GM; Yang F; Magdolen V; Kiechle M; Diamandis EP; Schmitt M
Thromb Haemost; 2013 Sep; 110(3):408-22. PubMed ID: 23765253
[TBL] [Abstract][Full Text] [Related]
20. Interdependence of kallikrein-related peptidases in proteolytic networks.
Beaufort N; Plaza K; Utzschneider D; Schwarz A; Burkhart JM; Creutzburg S; Debela M; Schmitt M; Ries C; Magdolen V
Biol Chem; 2010 May; 391(5):581-7. PubMed ID: 20302517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
